| ［1］ |
Carrera C, Scope A, Dusza SW, et al. Clinical and dermoscopic characterization of pediatric and adolescent melanomas: multicenter study of 52 cases［J］. J Am Acad Dermatol, 2018,78（2）:278⁃288. doi: 10.1016/j.jaad.2017.09.065.
|
| ［2］ |
Cordoro KM, Gupta D, Frieden IJ, et al. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children［J］. J Am Acad Dermatol, 2013,68（6）:913⁃925. doi: 10.1016/j.jaad.2012.12.953.
|
| ［3］ |
Sreeraman Kumar R, Messina JL, Reed D, et al. Pediatric melanoma and atypical melanocytic neoplasms［J］. Cancer Treat Res, 2016,167:331⁃369. doi: 10.1007/978⁃3⁃319⁃22539⁃5_15.
|
| ［4］ |
Kaste SC. Imaging of pediatric cutaneous melanoma［J］. Pediatr Radiol, 2019,49（11）:1476⁃1487. doi: 10.1007/s00247⁃019⁃04374⁃9.
|
| ［5］ |
Bahrami A, Barnhill RL. Pathology and genomics of pediatric melanoma: a critical reexamination and new insights［J］. Pediatr Blood Cancer, 2018,65（2）:10.1002/pbc.26792. doi: 10. 1002/pbc.26792.
|
| ［6］ |
Kinsler VA, O′Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi［J］. Br J Dermatol, 2017,176（5）:1131⁃1143. doi: 10.1111/bjd.15301.
|
| ［7］ |
Al⁃Himdani S, Naderi N, Whitaker IS, et al. An 18⁃year study of malignant melanoma in childhood and adolescence［J］. Plast Reconstr Surg Glob Open, 2019,7（8）:e2338. doi: 10.1097/GOX. 0000000000002338.
|
| ［8］ |
Saiyed FK, Hamilton EC, Austin MT. Pediatric melanoma: incidence, treatment, and prognosis［J］. Pediatric Health Med Ther, 2017,8:39⁃45. doi: 10.2147/PHMT.S115534.
|
| ［9］ |
Chrysouli K, Tsakanikos M, Stamataki S. A case report of melanoma as acute mastoiditis in a 10⁃month⁃old female child［J］. Case Rep Otolaryngol, 2019,2019:9641945. doi: 10.1155/2019/9641945.
|
| ［10］ |
Lim Y, Shin HT, Choi Y, et al. Evolutionary processes of melanomas from giant congenital melanocytic nevi［J］. Pigment Cell Melanoma Res, 2020,33（2）:318⁃325. doi: 10.1111/pcmr. 12829.
|
| ［11］ |
Motaparthi K, Kim J, Andea AA, et al. TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis［J］. J Cutan Pathol, 2020,47（8）:710⁃719. doi: 10.1111/cup.13691.
|
| ［12］ |
Goldstein AM, Stidd KC, Yang XR, et al. Pediatric melanoma in melanoma⁃prone families［J］. Cancer, 2018,124（18）:3715⁃3723. doi: 10.1002/cncr.31641.
|
| ［13］ |
Okamura R, Boichard A, Kato S, et al. Analysis of NTRK alterations in pan⁃cancer adult and pediatric malignancies: implications for NTRK⁃Targeted therapeutics［J］. JCO Precis Oncol, 2018,2018:PO.18.00183. doi: 10.1200/PO.18.00183.
|
| ［14］ |
Mitkov M, Chrest M, Diehl NN, et al. Pediatric melanomas often mimic benign skin lesions: a retrospective study［J］. J Am Acad Dermatol, 2016,75（4）:706⁃711.e4. doi: 10.1016/j.jaad.2016.05. 015.
|
| ［15］ |
Merkel EA, Mohan LS, Shi K, et al. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis［J］. Lancet Child Adolesc Health, 2019,3（9）:646⁃654. doi: 10.1016/S2352⁃4642（19）30116⁃6.
|
| ［16］ |
Kalani N, Guidry JA, Farahi JM, et al. Pediatric melanoma: characterizing 256 cases from the colorado central cancer registry［J］. Pediatr Dermatol, 2019,36（2）:219⁃222. doi: 10. 1111/pde.13747.
|
| ［17］ |
Kim J, Sun Z, Gulack BC, et al. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma［J］. J Pediatr Surg, 2016,51（6）:986⁃990. doi: 10.1016/j.jpedsurg.2016.02.067.
|
| ［18］ |
Afanasiev OK, Tu JH, Chu DH, et al. Characteristics of melanoma in white and nonwhite children, adolescents, and young adults: analysis of a pediatric melanoma institutional registry, 1995-2018［J］. Pediatr Dermatol, 2019,36（4）:448⁃454. doi: 10.1111/pde.13836.
|
| ［19］ |
Yan Y, Huang Y, Wang Y, et al. The first Chinese case of pediatric subungual melanoma: a case report and literature review［J］. Dermatol Ther, 2020,33（6）:e13918. doi: 10.1111/dth.13918.
|
| ［20］ |
Ulloa⁃Padilla JP, Khararjian A, Choi CJ. Cutaneous eyelid melanoma in an African American child［J］. Orbit, 2020:1⁃4. doi: 10.1080/01676830.2020.1799419.
|
| ［21］ |
Lorimer PD, White RL, Walsh K, et al. Pediatric and adolescent melanoma: a national cancer data base update［J］. Ann Surg Oncol, 2016,23（12）:4058⁃4066. doi: 10.1245/s10434⁃016⁃5349⁃2.
|
| ［22］ |
Miranda SG, Kashani⁃Sabet M, Zedek D, et al. Cutaneous Spitzoid melanoma in a very young girl of Asian descent［J］. BMJ Case Rep, 2011,2011:bcr0920103343 doi: 10.1136/bcr.09. 2010.3343.
|
| ［23］ |
Pillay K, Adams S, Vandermaesen L, et al. Acellular dermal matrix: treating periocular melanoma in a patient with xeroderma pigmentosa［J］. Plast Reconstr Surg Glob Open, 2017,5（8）:e1442. doi: 10.1097/GOX.0000000000001442.
|
| ［24］ |
Pfau D, Tamaki A, Hoppe KR, et al. Sentinel node biopsy in young patients with atypical melanocytic tumors of the head and neck［J］. OTO Open, 2019,3（2）:2473974X19850752. doi: 10. 1177/2473974X19850752.
|
| ［25］ |
Kim JY, Choi JE, Ahn HH, et al. A case of spitzoid melanoma with lymph node metastasis in a child［J］. J Korean Med Sci, 2012,27（4）:454⁃457. doi: 10.3346/jkms.2012.27.4.454.
|
| ［26］ |
Navid F, Herzog CE, Sandoval J, et al. Feasibility of pegylated interferon in children and young adults with resected high⁃risk melanoma［J］. Pediatr Blood Cancer, 2016,63（7）:1207⁃1213. doi: 10.1002/pbc.25983.
|
| ［27］ |
Mun SJ, Jung HY, Frolova A, et al. Malignant mucosal melanoma in the olfactory cleft of a 10⁃year⁃old child［J］. Auris Nasus Larynx, 2013,40（2）:235⁃238. doi: 10.1016/j.anl.2012.05. 001.
|
| ［28］ |
Marjanska A, Galazka P, Marjanski M, et al. Efficacy and toxicity of pembrolizumab in pediatric metastatic recurrent melanoma［J］. Anticancer Res, 2019,39（7）:3945⁃3947. doi: 10. 21873/anticanres.13547.
|
| ［29］ |
Baniak N, Podberezin M, Kanthan SC, et al. Primary pulmonary/pleural melanoma in a 13 year⁃old presenting as pleural effusion［J］. Pathol Res Pract, 2017,213（2）:161⁃164. doi: 10.1016/j.prp.2016.11.013.
|
| ［30］ |
Davis KL, Fox E, Merchant MS, et al. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma （ADVL1412）: a multicentre, open⁃label, single⁃arm, phase 1⁃2 trial［J］. Lancet Oncol, 2020,21（4）:541⁃550. doi: 10.1016/S1470⁃2045（20）30023⁃1.
|
| ［31］ |
MarjaŃska A, Drogosiewicz M, Dembowska⁃BagiŃska B, et al. Nivolumab for the treatment of advanced pediatric malignancies［J］. Anticancer Res, 2020,40（12）:7095⁃7100. doi: 10.21873/anticanres.14738.
|
| ［32］ |
Geoerger B, Kang HJ, Yalon⁃Oren M, et al. Pembrolizumab in paediatric patients with advanced melanoma or a PD⁃L1⁃positive, advanced, relapsed, or refractory solid tumour or lymphoma （KEYNOTE⁃051）: interim analysis of an open⁃label, single⁃arm, phase 1⁃2 trial［J］. Lancet Oncol, 2020,21（1）:121⁃133. doi: 10.1016/S1470⁃2045（19）30671⁃0.
|
| ［33］ |
Chisholm JC, Suvada J, Dunkel IJ, et al. BRIM⁃P: a phase I, open⁃label, multicenter, dose⁃escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation⁃positive melanoma［J］. Pediatr Blood Cancer, 2018,65（5）:e26947. doi: 10.1002/pbc.26947.
|
| ［34］ |
Subbiah V, Sen S, Hess KR, et al. Phase I study of the braf inhibitor vemurafenib in combination with the mammalian target of rapamycin inhibitor everolimus in patients with BRAF⁃mutated malignancies［J］. JCO Precis Oncol, 2018,2:PO.18. 00189. doi: 10.1200/PO.18.00189.
|
| ［35］ |
Endo C, Johnson TA, Morino R, et al. Genome⁃wide association study in Japanese females identifies fifteen novel skin⁃related trait associations［J］. Sci Rep, 2018,8（1）:8974. doi: 10.1038/s41598⁃018⁃27145⁃2.
|
| ［36］ |
Newman S, Fan L, Pribnow A, et al. Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas［J］. Nat Med, 2019,25（4）:597⁃602. doi: 10.1038/s41591⁃019⁃0373⁃y.
|
| ［37］ |
Ipenburg NA, Lo SN, Vilain RE, et al. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: a retrospective cohort study［J］. J Am Acad Dermatol, 2020,82（4）:910⁃919. doi: 10.1016/j.jaad.2019.10.065.
|
| ［38］ |
Pincheira MA, Bacharier LB, Castro⁃Rodriguez JA. Correction to: efficacy of macrolides on acute asthma or wheezing exacerbations in children with recurrent wheezing: a systematic review and meta⁃analysis［J］. Paediatr Drugs, 2020,22（2）:241. doi: 10.1007/s40272⁃020⁃00390⁃7.
|
